Market News

Mazor Robotics LTD (MZOR) Holding Upped by Menora Mivtachim Holdings Ltd; Gilead Sciences Com (GILD) Shareholder Muhlenkamp & Co Raised Holding by $13.85 Million

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Menora Mivtachim Holdings Ltd increased its stake in Mazor Robotics Ltd (MZOR) by 41.26% based on its latest 2017Q4 regulatory filing with the SEC. Menora Mivtachim Holdings Ltd bought 81,958 shares as the company’s stock rose 10.07% while stock markets declined. The institutional investor held 280,596 shares of the medical and dental instruments company at the end of 2017Q4, valued at $14.48 million, up from 198,638 at the end of the previous reported quarter. Menora Mivtachim Holdings Ltd who had been investing in Mazor Robotics Ltd for a number of months, seems to be bullish on the $1.59B market cap company. The stock increased 0.03% or $0.02 during the last trading session, reaching $59.8. About 213,628 shares traded. Mazor Robotics Ltd. (NASDAQ:MZOR) has risen 109.51% since May 17, 2017 and is uptrending. It has outperformed by 97.96% the S&P500.

Muhlenkamp & Co Inc increased its stake in Gilead Sciences Inc Com (GILD) by 761.77% based on its latest 2017Q4 regulatory filing with the SEC. Muhlenkamp & Co Inc bought 195,013 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 220,613 shares of the health care company at the end of 2017Q4, valued at $15.81 million, up from 25,600 at the end of the previous reported quarter. Muhlenkamp & Co Inc who had been investing in Gilead Sciences Inc Com for a number of months, seems to be bullish on the $88.08B market cap company. The stock increased 0.28% or $0.19 during the last trading session, reaching $67.74. About 2.16M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 17, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Berenberg on Thursday, September 22. Leerink Swann downgraded it to “Mkt Perform” rating and $94 target in Tuesday, September 27 report. The firm has “Hold” rating by Maxim Group given on Monday, August 28. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by BMO Capital Markets on Tuesday, January 2. Piper Jaffray maintained the shares of GILD in report on Wednesday, February 3 with “Overweight” rating. Bank of America maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, October 4 with “Neutral” rating. The stock has “Hold” rating by Argus Research on Friday, July 29. On Tuesday, January 30 the stock rating was upgraded by Citigroup to “Buy”. The rating was upgraded by Bank of America on Friday, January 15 to “Neutral”. The rating was maintained by Morgan Stanley with “Equal-Weight” on Friday, October 6.

Since January 2, 2018, it had 0 insider buys, and 22 insider sales for $44.80 million activity. Alton Gregg H sold $1.11M worth of stock or 15,000 shares. Cogan John Francis sold $431,117 worth of stock or 5,833 shares. On Wednesday, February 21 Washington Robin L sold $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,000 shares. On Friday, February 9 WILSON GAYLE E sold $4.68M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 60,000 shares. 100,000 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $8.02M were sold by Meyers James R.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It fall, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Ameritas Inv Prtn reported 64,551 shares. Fisher Asset Ltd Llc accumulated 0.04% or 442,774 shares. Axa invested in 0.38% or 1.33 million shares. Moreover, Verition Fund Limited Com has 0.16% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 24,192 shares. Retirement Of Alabama has 1.05M shares for 0.36% of their portfolio. Chevy Chase Tru Inc holds 0.35% or 1.14M shares. Umb Bankshares N A Mo has invested 0.27% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Palisade Cap Mgmt Lc Nj stated it has 9,235 shares or 0.02% of all its holdings. Marshall & Sullivan Inc Wa stated it has 1.3% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 24,312 are held by Ionic Ltd. Howe Rusling Incorporated has invested 0.18% in Gilead Sciences, Inc. (NASDAQ:GILD). Liberty Cap Management reported 1,360 shares. 66,000 were reported by Omers Administration. Moreover, Needham Mgmt Ltd Liability has 3.07% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Blue Fincl reported 3,913 shares or 0.16% of all its holdings.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “FDA OKs expanded use for Gilead’s Truvada” on May 15, 2018, also Bizjournals.com with their article: “2 big Bay Area companies look to map, tackle inflammatory diseases” published on April 30, 2018, Seekingalpha.com published: “Kite Pharma continues buildout for cell therapy manufacture” on May 15, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead Sciences (GILD) Presents at Bank of America Merrill Lynch 2018 Healthcare Conference (Transcript)” published on May 16, 2018 as well as 247Wallst.com‘s news article titled: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” with publication date: May 02, 2018.

Among 7 analysts covering Mazor Robotics (NASDAQ:MZOR), 2 have Buy rating, 3 Sell and 2 Hold. Therefore 29% are positive. Mazor Robotics had 18 analyst reports since November 20, 2015 according to SRatingsIntel. The stock of Mazor Robotics Ltd. (NASDAQ:MZOR) earned “Buy” rating by Standpoint Research on Friday, July 8. The stock of Mazor Robotics Ltd. (NASDAQ:MZOR) has “Hold” rating given on Wednesday, August 30 by Needham. The firm has “Sell” rating by Needham given on Friday, March 16. On Wednesday, April 19 the stock rating was downgraded by Standpoint Research to “Reduce”. As per Thursday, May 19, the company rating was upgraded by Wells Fargo. On Wednesday, August 2 the stock rating was maintained by Needham with “Hold”. The company was downgraded on Thursday, October 19 by Barclays Capital. The rating was maintained by Needham on Thursday, October 5 with “Hold”. The firm has “Neutral” rating given on Tuesday, May 31 by Sterne Agee CRT. Needham maintained Mazor Robotics Ltd. (NASDAQ:MZOR) on Thursday, July 6 with “Hold” rating.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *